New Delhi: Diagnostics and healthcare services provider Chandan Healthcare on Tuesday said its board has approved a Rs 104.13 crore fundraise through a preferential issue of warrants and an exclusive nationwide diagnostic partnership with Jeena Sikho Lifecare Ltd .

The board has approved the issuance of up to 44,50,000 fully convertible equity warrants on a preferential basis at an issue price of Rs 234 per warrant, aggregating to approximately Rs 104.13 crore, according to an exchange filing.

The issue has been structured to include both promoter group participation and strategic institutional investors, underscoring strong market confidence in the company's future growth trajectory it added.

Chandan Healthcare has also entered into an exclusive strategic partnership with Ayurved

See Full Page